RecruitingNCT06319911

AETOS Shoulder System

AETOS Shoulder System Post Market Clinical Investigation


Sponsor

Smith & Nephew, Inc.

Enrollment

220 participants

Start Date

Mar 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called AETOS for people with shoulder arthritis and shoulder osteoarthritis. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAETOS

The AETOS Shoulder System will be implanted into the right or left shoulder in the anatomic or reverse configuration


Locations(5)

California Pacific Orthopedics

San Francisco, California, United States

Western Orthopaedics

Denver, Colorado, United States

Hughston Foundation

Columbus, Georgia, United States

Center for Orthopedics and Neurosurgical Care

Bend, Oregon, United States

Rothman Institute

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06319911


Related Trials